底的根除
发表于 2025-3-21 16:43:52
书目名称Ischemic Stroke Therapeutics影响因子(影响力)<br> http://figure.impactfactor.cn/if/?ISSN=BK0475539<br><br> <br><br>书目名称Ischemic Stroke Therapeutics影响因子(影响力)学科排名<br> http://figure.impactfactor.cn/ifr/?ISSN=BK0475539<br><br> <br><br>书目名称Ischemic Stroke Therapeutics网络公开度<br> http://figure.impactfactor.cn/at/?ISSN=BK0475539<br><br> <br><br>书目名称Ischemic Stroke Therapeutics网络公开度学科排名<br> http://figure.impactfactor.cn/atr/?ISSN=BK0475539<br><br> <br><br>书目名称Ischemic Stroke Therapeutics被引频次<br> http://figure.impactfactor.cn/tc/?ISSN=BK0475539<br><br> <br><br>书目名称Ischemic Stroke Therapeutics被引频次学科排名<br> http://figure.impactfactor.cn/tcr/?ISSN=BK0475539<br><br> <br><br>书目名称Ischemic Stroke Therapeutics年度引用<br> http://figure.impactfactor.cn/ii/?ISSN=BK0475539<br><br> <br><br>书目名称Ischemic Stroke Therapeutics年度引用学科排名<br> http://figure.impactfactor.cn/iir/?ISSN=BK0475539<br><br> <br><br>书目名称Ischemic Stroke Therapeutics读者反馈<br> http://figure.impactfactor.cn/5y/?ISSN=BK0475539<br><br> <br><br>书目名称Ischemic Stroke Therapeutics读者反馈学科排名<br> http://figure.impactfactor.cn/5yr/?ISSN=BK0475539<br><br> <br><br>
menopause
发表于 2025-3-21 20:17:29
http://reply.papertrans.cn/48/4756/475539/475539_2.png
否认
发表于 2025-3-22 02:57:18
http://image.papertrans.cn/i/image/475539.jpg
Esophagitis
发表于 2025-3-22 06:18:42
978-3-031-49965-4The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerl
纬线
发表于 2025-3-22 12:40:00
http://reply.papertrans.cn/48/4756/475539/475539_5.png
LATER
发表于 2025-3-22 14:16:34
http://reply.papertrans.cn/48/4756/475539/475539_6.png
Grating
发表于 2025-3-22 17:09:38
Lina Palaiodimou,Aristeidis H. Katsanos,Georgios Tsivgoulis
杀菌剂
发表于 2025-3-22 22:14:51
Anas Alrohimi,Ashfaq Shuaib,Rajsrinivas Parthasarathy,Mahesh Pundlik Kate
间接
发表于 2025-3-23 02:11:40
http://reply.papertrans.cn/48/4756/475539/475539_9.png
不合
发表于 2025-3-23 05:39:20
Neuroprotectantsinvestigators with a blueprint for systematically testing the most promising therapies preclinically analogous to clinical trials. Together, these basic, translational, and clinical advances hold the promise of developing novel neuroprotective therapies and greatly improving stroke patient outcomes.